TechGROWTH Ohio portfolio company OsteoDx receives $2M grant from the National Institutes of Health
TechGROWTH Ohio portfolio company OsteoDx receives $2M grant from the National Institutes of Health Published: May 19, 2021 Author: Staff reports OsteoDx Inc., a TechGROWTH Ohio portfolio company, has been selected for funding through a Small Business Innovation Research (SBIR) Phase II grant with the National Institutes of Health. The grant will provide $2M in support of a multicenter study to further measure and validate the efficacy of the companyโs proprietary Cortical Bon...
United States Ohio University Brian Clark Gary Wakeford Ohio University Voinovich School Of Leadership Small Business Innovation Research
Source: ohio.edu